Table 1.
Stimulation | CD56+/CD14− |
CD56−/CD14− |
||||||
---|---|---|---|---|---|---|---|---|
6 hours |
24 hours |
6 hours |
24 hours |
|||||
IFN-γ | IL-8 | IFN-γ | IL-8 | IFN-γ | IL-8 | IFN-γ | IL-8 | |
IL-12 | 0.94 ± 0.81 | 0.14 ± 0.02 | 0.07 ± 0.04 | 0.13 ± 0.01 | 1.52 ± 0.49 | 0.34 ± 0.02 | 0.21 ± 0.09 | 0.34 ± 0.05 |
IL-18 | 0.01 ± 0.02 | 0.14 ± 0.03 | ND | 0.52 ± 0.47 | 0.44 ± 0.08 | 0.36 ± 0.07 | 0.15 ± 0.06 | 0.47 ± 0.09 |
IL-12 + IL-18 | 3.29 ± 3.04 | 0.12 ± 0.01 | 126 ± 58.4 | 7.92 ± 5.38 | 0.33 ± 0.09 | 0.30 ± 0.11 | 11.3 ± 3.82 | 0.46 ± 0.07 |
The relative ability of the CD56+/CD14− and the CD56−/CD14− subpopulations of lymphocytes to express IFN-γ and IL-8 was measured by ELISA. Human lymphocytes were isolated from PBMCs after CD14 depletion, and 5 × 106 cells were stimulated with rIL-12 (10 ng/mL) and rIL-18 (10 ng/mL) for 6 hours and 24 hours. The cell supernatants were analyzed for IFN-γ and IL-8 release. Values are mean ± SD for 2 experiments.
ND indicates not detected.